Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion description "[Fifty-four patients with Ph-negative MPN (including 21 essential thrombocythemia [ET], 21 polycythemia vera [PV], 7 primary myelofibrosis, and 5 unclassified MPN) who had progressed to AML (n = 26) or MDS (n = 28) were treated with azacitidine in a patient-named program.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion evidence source_evidence_literature NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion SIO_000772 20664061 NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion wasDerivedFrom befree-20140225 NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_assertion wasGeneratedBy ECO_0000203 NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP531059.RATeFNJEqPd_qB7J6h9TWzWo2YHI7jH4YP6Dh-jzhcfbM130_provenance.